✦ LIBER ✦

The LUNDEX, a new index of drug efficacy in clinical practice: Results of a five-year observational study of treatment with infliximab and etanercept among rheumatoid arthritis patients in southern Sweden

✍ Scribed by Lars Erik Kristensen; Tore Saxne; Pierre Geborek

Publisher: John Wiley and Sons
Year: 2006
Tongue: English
Weight: 258 KB
Volume: 54
Category: Article
ISSN: 0004-3591
DOI: 10.1002/art.21570

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Direct comparison of treatment responses

Direct comparison of treatment responses, remission rates, and drug adherence in patients with rheumatoid arthritis treated with adalimumab, etanercept, or infliximab: Results from eight years of surveillance of clinical practice in the nationwide Danish DANBIO registry

✍ Merete Lund Hetland; Ib Jarle Christensen; Ulrik Tarp; Lene Dreyer; Annette Hans 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 124 KB 👁 2 views

The comparative one-year performance of

The comparative one-year performance of anti–tumor necrosis factor α drugs in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: Results from a longitudinal, observational, multicenter study

✍ Heiberg, Marte Schrumpf ;Koldingsnes, Wenche ;Mikkelsen, Knut ;Rødevand, Erik ;K 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 166 KB

Infliximab inhibits progression of radio

Infliximab inhibits progression of radiographic damage in patients with active psoriatic arthritis through one year of treatment: Results from the induction and maintenance psoriatic arthritis clinical trial 2

✍ D. van der Heijde; A. Kavanaugh; D. D. Gladman; C. Antoni; G. G. Krueger; C. Guz 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 121 KB 👁 1 views